January 13, 2014
Author(s)
Elisabeth Mansfield, Tammy L. Oreskovic, Nikki S. Rentz, Kavita M. Jeerage
In evaluating nanoparticle risks to human health, there is often a disconnect between results obtained from in vitro toxicology studies and in vivo activity, prompting the need for improved methods to rapidly assess the hazards of engineered nanomaterials